We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Bsf Enterprise Plc | BSFA | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.50 | 10.53% | 5.25 | 09:00:21 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.75 | 4.75 | 5.25 | 5.25 | 4.75 |
| Industry Sector |
|---|
| GENERAL FINANCIAL |
| Top Posts |
|---|
Posted at 23/4/2024 12:15 by le mass du pap Been a few on here, LSE and of course X/twitter trying to spread fear about a discounted placing. This has obviously affected sentiment and therefore the price. The company clearly stated in a recent RNS that they are funded and have no plans to do a fundraise. I've just seen this email, again confirming there are no plans for a placing and there has been no change in that position. Not sure how much clearer the company could be. Of course that won't stop the usual suspects from playing their games. BSFA is very oversold imho.Dear, Thank you for your email. BSF Enterprise continues to progress and achieve its strategic objectives laid out at the beginning of the year. The Company is sufficiently funded for all near-term activity and has no current plans for a fundraise. Any additional funding may be achieved at a subsidiary level to prevent the dilution of shareholders. There has been no change in that position Thank you for your continued support. Regards, Miao He BSF Enterprise PLC |
Posted at 28/11/2023 13:50 by sphere25 Had a go here last November (15th November 2022 Post 37) on the major news that day. It worked out well for a trade, but a year on, still sat here wondering the same thing:"When you look at these announcements, you sit and wonder just how far these things could go and how big they could eventually get. The problem is it is Penny Punt Land, where the reality is a minority making it really big, and losses for the near majority eventually coming to the fore. Clearly these moments of excitement can provide profitable short term opportunities too" Looking around the market, it has just been a systematic annihilation of the majority of these sorts of penny punt/highly speculative shares. The forums are almost a testament to that, being graveyard like. It won't stop in this normalised higher rate environment - the market will continue on its brutal streak of cleansing. The update from BSFA on Friday was interesting. Major names in the mix here from the update. In a different market a highly speculative share like this goes screaming north on that update alone. In this market it is almost the theme now that a positive new release will result in limited movement higher or a quick sell back down. It goes like this: --> Positive news release --> Market makers mark the price up --> A little surge in buying that fizzles out --> Big sellers sat in the background sell into the little spike to overwhelm the buyers and kill off any momentum --> Price ends up stalling and then coming back down Watched a fair few of these, and it is almost pointless having a go, unless there is blowout buying coming in. I suspect BSFA will need at least a double digit millions day to have a chance of real momentum. I can see a little pop today with just over 2m shares trade. Myles Mcnulty along with others on X clearly have influence. Interestingly, right now they have more influence than the likes of Simon Thompson of IC, Robbie Burns (Naked Trader) and even SCSW where there is very little influence nowadays, sometimes just the odd few buys with the old guard tipsters/commentator Barring some real game changing announcement here (and elsewhere) in these highly speculative shares, I don't see how the market will change its view on them. The market will constantly look more at the need for funding (than the bullish updates) and the price will just drift expecting another placing. If you have 18 months of cash, in 6 months time the market is looking even more strongly toward the financing side, so the bullish news has to be transformational, or market sentiment has to change in a material way. That said, this is one of the few that did catch the eye last year and still looks interesting. It might be a 10/90 against sort of play, but it stays on the watchlist to see if any big buying does eventually come in. In the graveyard of hundreds, there are still the odd few that can make it big. Wonder if this is one of them. Maybe come back in another year to comment :-) All imo DYOR |
Posted at 24/11/2023 07:55 by walter walcarpets RNS Number : 5345UBSF Enterprise PLC 24 November 2023 24 November 2023 BSF Enterprise PLC ("BSF" or the "Company") 3D Bio-Tissues Product Partnership Progress BSF (LSE: BSFA), (OTCQB: BSFAF), the Main Market listed biotech company and owner of pioneering UK-based clinical and cellular agriculture company 3D Bio-Tissues (3DBT), provides an update on the Company's partnership progress across several of 3DBT's product verticals. Etsyl (TM) Commercial Update 3DBT is pleased to announce that it has entered into a proof-of-concept contractual agreement with one of the largest cosmetic companies in the world, which will test the suitability of the Company's proprietary lipopeptide product, Etsyl(TM), for use within its skin cream cosmetic solutions. 3DBT is harnessing the natural regenerative ability of human skin cells to drive rapid tissue regeneration and repair. Its Etsyl(TM) promotes cellular collagen production in human skin cells, with cosmetic and pharmacological applications as a bioactive ingredient in skincare formulations for the fabrication of native-like skin substitutes for clinical, cosmetic and industrial applications. The cosmetic company which BSF is working with specialises in the research and development of bioactive ingredients for skin care which, with proven efficacy, can aid in anti-ageing, moisturising and acne control. EIT Grant In September 2023, 3D Bio-Tissues announced that it has been awarded a EUR612,000 grant from the European Institute of Innovation and Technology ("EIT Food") to upscale the production and sales of its proprietary serum-free media, City-Mix(TM). City-Mix(TM) is an animal-free cell growth agent for culturing skin, muscle and fat cells for use in cultivated meat and leather production. Further to this, 3DBT is pleased to announce that it now has two new staff members in place to focus on securing additional procurement, manufacturing and distribution partnerships in the food-tech and biotech sectors, including Mr Adam Crosby, an operational manager with broad-level experience across multiple industries, and a successful track record in delivering multi-million-pound projects and facilitating growth. The Company has also hired an experienced Technical Sales Specialist to strengthen its sales team. Book launch Chief Executive of 3DBT, Professor Che Connon, has co-authored a book entitled Advances in Cultured Meat Technology, that explores the potential of cultured meat production in solving food security. Publication of the book is expected to further enhance Professor Connon, and the Company's international profile and reputation within the rapidly advancing cultured meat industry. Che Connon, Chief Executive of 3DBT and Managing Director of BSF said: "We are delighted to be working with one of the world's largest cosmetic companies, which highlights the potential of our Etsyl product and the diverse applications of our technology. Furthermore, with an enlarged team in hand, we hope to secure further partnerships and sales for our various product offerings at an accelerated pace, and we look to the future with confidence." For further enquiries, pleas |
Posted at 16/10/2023 18:53 by le mass du pap Probably. Price action now has nothing to do with fundamentals. Anyone selling now is doing so because they have to, or releasing funds at a loss to chase something else. BSFA is not unique in this respect. The market makers systems are always more patient than any retail trader and they always benefit from periods like this, that they helped to create. "Build it and they will come", or 'go' as the case may be. I personally doubt it will reach 6p as our perma-bear kcowe suggests. Too many not wanting to miss the bottom and waiting for the starting pistol, at which point it'll become a bunfight to buy. I will. |
Posted at 21/9/2023 08:16 by snowy20 3 buys to start today off . Have the sellers finished selling for the moment at bsfa . |
Posted at 14/9/2023 10:57 by snowy20 Sold some more this morning to move it over HE1 for a number of days with drilling due to start at HE1 up,Now have some more bsfa shares hoping a bsfa rns might be released soon .So many look be getting impatient with bsfa ,Was not helped with last weeks rns which some seen as a pointless RNS . |
Posted at 02/8/2023 14:00 by jailbird "US companies are raising millions because they are manufacturers who need large factories etc to make their meat. BSFA is not a manufacturer! They only produce the CityMix that the manufacturers use to produce their meat. And BSFA have already increased capacity to produce CityMix from the last placing"If BSFA do not intend to manufacture meat then I agree with you |
Posted at 02/8/2023 09:31 by le mass du pap And btw, US companies are raising millions because they are manufacturers who need large factories etc to make their meat. BSFA is not a manufacturer! They only produce the CityMix that the manufacturers use to produce their meat. And BSFA have already increased capacity to produce CityMix from the last placing.I think you have proved how this is still misunderstood and maybe that's still a problem, although the company is quite clear, people just need to do their research.. |
Posted at 23/6/2023 15:45 by simonsmithiv US investors are not as beaten down as UK one's, so lets hope BSFA can tap that potential. I'm of the opinion this roadshow and the current mcap will simply see 3DBT bought from BSFA with a special dividend to us and onto the next venture. Something like £50-70m is peanuts to these players and that was Shard's fair value before the US approved lab meat. BSFA is an investment vehicle after all and 3DBT is an investment. Either that or the CityMix patent/rights being bought outright for meat and 3DBT retain rights for leather, skin etc. At the very least we'll surely see some deals on CityMix licensing. Either way, risk/reward at this lowly mcap is insane and in weeks/months to come it'll be a lot higher imho. |
Posted at 15/5/2023 08:25 by hb2020 @MylesMcNultyVery positive update from @BSF_Enterprise. It has successfully created samples of animal animal skin tissue - which, using the paraphernalia on my desk, is about the size of a calculator. #BSFA has now "engaged with a number of companies within the leather industry in the UK and abroad regarding potential Proof of Concept engagements to establish the suitability of the skin product as a sustainable, ethical alternative to traditional leather goods." The global leather goods market is projected to reach $400bn+ by 2030. Add this to the colossal sizes of the global meat market ($1.3 trillion in 2023) and the global seafood market (~$300bn in 2023)... And one can perceive the scale of the long-term commercial opportunity ahead for BSFA. Particularly important to the BSFA investment case is that the leather goods industry naturally has substantially lower barriers to entry, re: regulatory bodies, than do the meat/seafood markets, for cultured versions (no FDA / FSA to contend with!). Moreover, whilst there's a big issue with 'the ick factor', when it comes to cultured meat/seafood, there should be no such issue with cultured leather. Indeed, removing the need for animal slaughter from the leather goods industry should gather immense support from the majority in society. Key for me is that #BSFA is already pushing ahead with commercialization across multiple business lines. It is now generating revenue from the sale of City-Mix to multiple customers; is in talks with prospective customers for its cultured leather; and is nearing a major inflection point with the reveal of its first full-size pork fillets. I suspect that licensing talks for its tissue templating technology, to produce cultured meat, will commence in H2, post that showcase event in the coming weeks. Overall, delighted with progress and consider the current market cap, at £14.5m (and EV of only £12m!), incredibly undervalued |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
